Usability of a Mobile Phone App Aimed at Adolescents and Young Adults During and After Cancer Treatment: Qualitative Study.

AYA adolescent and young adult app cancer co-creation mHealth mobile phone think-aloud test usability

Journal

JMIR cancer
ISSN: 2369-1999
Titre abrégé: JMIR Cancer
Pays: Canada
ID NLM: 101666844

Informations de publication

Date de publication:
02 Jan 2020
Historique:
received: 19 06 2019
accepted: 17 10 2019
revised: 22 08 2019
entrez: 3 1 2020
pubmed: 3 1 2020
medline: 3 1 2020
Statut: epublish

Résumé

Adolescent and young adult (AYA) cancer patients are seldom involved in the process of testing cancer-related apps. As such, knowledge about youth-specific content, functionalities, and design is sparse. As a part of a co-creation process of developing the mobile phone app Kræftværket, AYAs in treatment for cancer and in follow-up participated in a usability think-aloud test of a prototype of the app. Thus, the app was initiated, created, and evaluated by AYAs with cancer experience. The aim of this study was to explore the results of a think-aloud test administered to see how the prototype of the app Kræftværket was used by AYAs in treatment for cancer and in follow-up, and to investigate the strengths and weaknesses of the app. A total of 20 AYA cancer patients aged 16 to 29 years (n=10 on treatment, n=10 in follow-up) were provided with the first version of the co-created mobile phone app Kræftværket during a 6-week test period (April-May 2018). After the test period, 15 participated in individual usability think-aloud tests. The tests were video-recorded, transcribed verbatim, and analyzed using a thematic analysis approach. The thematic analysis led to the following themes and subthemes: navigation (subthemes: intuition, features, buttons, home page, profile), visual and graphic design (subthemes: overview, text and colors, photos, videos, YouTube), and usefulness (subthemes: notifications, posts, adding). The analysis identified gender differences in app utilization-female participants seemed to be more familiar with parts of the app. The app seemed to be more relevant to AYAs receiving treatment due to app functions such as tracking symptoms and searching for relevant information. Lack of notifications and incorrect counting of posts were perceived as barriers to using the app. Usability testing is crucial to meet the needs of the AYA target audience. AYA cancer apps should preferably be relevant, targeted, and unique, and include a tracking function and AYA-produced videos. Notifications and correct marking and ordering of posts are critical to make apps engaging and dynamic. Further research is recommended to evaluate the Kræftværket app with the input of more AYAs.

Sections du résumé

BACKGROUND BACKGROUND
Adolescent and young adult (AYA) cancer patients are seldom involved in the process of testing cancer-related apps. As such, knowledge about youth-specific content, functionalities, and design is sparse. As a part of a co-creation process of developing the mobile phone app Kræftværket, AYAs in treatment for cancer and in follow-up participated in a usability think-aloud test of a prototype of the app. Thus, the app was initiated, created, and evaluated by AYAs with cancer experience.
OBJECTIVE OBJECTIVE
The aim of this study was to explore the results of a think-aloud test administered to see how the prototype of the app Kræftværket was used by AYAs in treatment for cancer and in follow-up, and to investigate the strengths and weaknesses of the app.
METHODS METHODS
A total of 20 AYA cancer patients aged 16 to 29 years (n=10 on treatment, n=10 in follow-up) were provided with the first version of the co-created mobile phone app Kræftværket during a 6-week test period (April-May 2018). After the test period, 15 participated in individual usability think-aloud tests. The tests were video-recorded, transcribed verbatim, and analyzed using a thematic analysis approach.
RESULTS RESULTS
The thematic analysis led to the following themes and subthemes: navigation (subthemes: intuition, features, buttons, home page, profile), visual and graphic design (subthemes: overview, text and colors, photos, videos, YouTube), and usefulness (subthemes: notifications, posts, adding). The analysis identified gender differences in app utilization-female participants seemed to be more familiar with parts of the app. The app seemed to be more relevant to AYAs receiving treatment due to app functions such as tracking symptoms and searching for relevant information. Lack of notifications and incorrect counting of posts were perceived as barriers to using the app.
CONCLUSIONS CONCLUSIONS
Usability testing is crucial to meet the needs of the AYA target audience. AYA cancer apps should preferably be relevant, targeted, and unique, and include a tracking function and AYA-produced videos. Notifications and correct marking and ordering of posts are critical to make apps engaging and dynamic. Further research is recommended to evaluate the Kræftværket app with the input of more AYAs.

Identifiants

pubmed: 31895046
pii: v6i1e15008
doi: 10.2196/15008
pmc: PMC6966550
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e15008

Informations de copyright

©Signe Hanghøj, Kirsten A Boisen, Maiken Hjerming, Abbey Elsbernd, Helle Pappot. Originally published in JMIR Cancer (http://cancer.jmir.org), 02.01.2020.

Références

J Med Internet Res. 2016 May 16;18(5):e97
pubmed: 27185295
J Med Syst. 2015 Feb;39(2):1
pubmed: 25600193
JMIR Mhealth Uhealth. 2018 Dec 06;6(12):e11271
pubmed: 30522990
Int J Med Inform. 2013 Jul;82(7):593-603
pubmed: 23507561
JMIR Mhealth Uhealth. 2019 Oct 3;7(10):e13829
pubmed: 31584008
J Cancer Surviv. 2017 Aug;11(4):498-504
pubmed: 28342093
J Med Internet Res. 2013 Mar 08;15(3):e51
pubmed: 23475457
JCO Clin Cancer Inform. 2018 Dec;2:1-15
pubmed: 30652583
JMIR Mhealth Uhealth. 2018 Feb 28;6(2):e43
pubmed: 29490897
Int J Med Inform. 2019 Jun;126:95-104
pubmed: 31029270
J Med Internet Res. 2011 Jan 17;13(1):e7
pubmed: 21247864
J Pediatr Oncol Nurs. 2006 Jul-Aug;23(4):200-9
pubmed: 16766685
Front Public Health. 2017 Apr 03;5:39
pubmed: 28421175
JMIR Mhealth Uhealth. 2018 Apr 11;6(4):e86
pubmed: 29643054
Pediatr Blood Cancer. 2018 Nov;65(11):e27278
pubmed: 29943893
JMIR Ment Health. 2018 Feb 15;5(1):e13
pubmed: 29449202
J Med Internet Res. 2015 Dec 23;17(12):e287
pubmed: 26701961
J Pediatr Oncol Nurs. 2015 Mar-Apr;32(2):70-82
pubmed: 25037173
Glob Qual Nurs Res. 2016 Mar 8;3:2333393616631678
pubmed: 28462329
PLoS One. 2016 May 23;11(5):e0156164
pubmed: 27214203
Int J Environ Res Public Health. 2018 Oct 29;15(11):
pubmed: 30380692
JMIR Res Protoc. 2018 May 10;7(5):e10098
pubmed: 29748162
Health Informatics J. 2019 Feb 8;:1460458218824734
pubmed: 30732520
J Biomed Inform. 2016 Apr;60:243-51
pubmed: 26903153
Int J Med Inform. 2018 Oct;118:54-57
pubmed: 30153922
Adolesc Health Med Ther. 2015 Aug 18;6:141-8
pubmed: 26316835
JMIR Mhealth Uhealth. 2019 Jan 17;7(1):e11838
pubmed: 30664472
JMIR Mhealth Uhealth. 2014 Aug 13;2(3):e33
pubmed: 25119490
Pediatr Blood Cancer. 2017 Jan;64(1):139-145
pubmed: 27574031
J Adolesc Young Adult Oncol. 2013 Jun;2(2):44-52
pubmed: 23781400
Telemed J E Health. 2016 Feb;22(2):170-175
pubmed: 26258994
Ann Behav Med. 2007 Jun;33(3):221-35
pubmed: 17600449
Adolesc Health Med Ther. 2018 May 01;9:77-85
pubmed: 29750063
Cancer. 2006 Dec 15;107(12):2915-23
pubmed: 17103383
JMIR Form Res. 2018 Sep 13;2(2):e10055
pubmed: 30684424
Psychooncology. 2015 Sep;24(9):1104-15
pubmed: 25611943
JMIR Mhealth Uhealth. 2017 Dec 18;5(12):e190
pubmed: 29254914
J Med Internet Res. 2015 Nov 27;17(11):e270
pubmed: 26614438
Digit Health. 2017 Apr 12;3:2055207617704273
pubmed: 29942594
PLoS One. 2018 Jul 26;13(7):e0201166
pubmed: 30048546
J Cancer Educ. 2013 Mar;28(1):138-42
pubmed: 23275239
JMIR Form Res. 2018 Nov 01;2(2):e23
pubmed: 30684439
JMIR Mhealth Uhealth. 2017 Aug 08;5(8):e109
pubmed: 28790022
Pediatr Blood Cancer. 2017 Oct;64(10):null
pubmed: 28423223

Auteurs

Signe Hanghøj (S)

Center of Adolescent Medicine, Department of Paediatrics and Adolescent Medicine, The Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Kirsten A Boisen (KA)

Center of Adolescent Medicine, Department of Paediatrics and Adolescent Medicine, The Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Maiken Hjerming (M)

Department of Hematology, Department of Paediatrics and Adolescent Medicine, The Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Abbey Elsbernd (A)

University of Kansas School of Medicine, Kansas City, KS, United States.

Helle Pappot (H)

Department of Oncology, The Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Classifications MeSH